Copyright
        ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
    
    
        World J Gastroenterol. Jun 7, 2006; 12(21): 3386-3392
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3386
    Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3386
        Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: Responders versus nonresponders
    
    
    Tryggve Ljung, Sofie Lundberg, Mark Varsanyi, Catharina Johansson, Per M Hellström, Peter Thelin Schmidt,  Department of Gastroenterology and Hepatology,  Karolinska University Hospital,  Site Solna,  Stockholm,  Sweden
Max Herulf, Jon O Lundberg, Department of Physiology and Pharmacology,  Karolinska Institutet,  Stockholm,  Sweden
    Supported by the Swedish Research Council, Novo Nordisk and the Bengt Ihre fund
Correspondence to:  Tryggve Ljung, MD, PhD, Department of Gastroenterology and Hepatology, Karolinska University Hospital, Site Solna, SE-171 76 Stockholm, Sweden. tryggve.ljung@hotmail.com
Telephone:  +46-8-51773877 Fax: +46-8-51772058
Received: October 12, 2005
Revised: October 28, 2005
Accepted: November 10, 2005
Published online: June 7, 2006
    Revised: October 28, 2005
Accepted: November 10, 2005
Published online: June 7, 2006
    Core Tip

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        